Further, data from the Surveillance, Epidemiology, and End Results registry show that hormone receptor positive, HER2‐negative, or positive breast cancer accounts for 83% of those patients with known receptor status reported in 2010.3 Here, ERBB2 is linked to breast carcinoma.